Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Need the momentum to continue :)
Looking good today..
COEP news... notice of delisting or failure to satisfy a continued listing rule or standard from Nasdaq
No interest in it sad
Who would have thought this would have did a 3:1 reverse split at $3, start trading at $9 and then drop all the way down to $1 AFTER the split.
Coeptis Therapeutics Holdings to Ring the Nasdaq Stock Market Opening Bell
Source: PR Newswire (US)
WEXFORD, Pa., Nov. 15, 2022 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced that President, Chairman and CEO Dave Mehalick and other members of the management team will ring the Nasdaq Opening Bell on Wednesday, Nov. 16, 2022.
I’m holding through. These types of plays can change in an instance.
hard to know sad nonetheless
Looks like volume is slowing down. Maybe the worst is done…. Hopefully
Hard to tell where to buy as it’s literally catching a fallen knife. No charts to predict bottom….
down 66% absolutely pathetic
Christ. At $2.18, this is just about as low as pre-uplist.
yea not really an IPO but why go thru all this
I’m hoping they didn’t IPO for nothing.
we can hope needs a miracle
Oh. Ok. That’s still likely too considering COEP/BHSE went to $21 recently.
no the stock not the warrant COEP need to get to $23 then the warrant will trade parabolicly
That would be absolutely life changing from .05 to $23.
no it has to get to $23 thats the strike price once it gets there the warrants are exercisable and the warrants move big
So each warrant will be worth $23?
I wonder why everything came down so hard??
I’m glad I got the warrants. Not as much swing and still at a premium….I think
It’s not over lol
Well this didn’t go as I expected.
COEP: Shareholders of Coeptis Therapeutics, Inc. (COEP) will receive 1 share of Coeptis Therapeutics Holdings Inc. common stock for every 2.96851721 shares of COEP held.
FINRA deleted symbol.
https://otce.finra.org/otce/dailyList?viewType=Deletions
$BHSE $BHSEW $COEP the warrants $BHSEW are still cheap, otcs to NASD via a spac are huge, no offering, you're getting it early here. Warrants, each whole warrant exercisable for one-half of one Ordinary Share for $11.50 per whole share, so looks like at $23
COEP will be uplisting via a SPAC BHSE at a ratio of 2.9 could be a wild one of the otc to NASD runners. COEP is now 3, which equals 8.7 for BHSE, there is also BHSEW warrants that look cheap 8k https://www.otcmarkets.com/filing/html?id=16157944&guid=jEz-kemBceBUdth
Is this ever going to move. Doesn’t seem like it’s ready if there’s no buying.
At lease $BHSE is tagged in that tweet
Tweet COEP
@coeptistx has entered into an exclusive license agreement with @PittTweet for the rights to SNAP-CAR, a #CARTCellTherapy designed to potentially address #hematologic and #solidtumors, including #breastcancer and #ovariancancer. $COEP $BHSE
— Coeptis Therapeutics (@coeptistx) September 21, 2022
Read more: https://t.co/lsYTuJMqjH pic.twitter.com/F77VcOPbJI
Is this merger ever going through?
Gosh. How low is this going to go. Starting to look like trash.
Good thing we don’t rely on timelines lol
sure hope so, everything seems to always take longer
I guess July wasn’t our month…. Hopefully August is better. I wonder if this is still on track?
Those $2.99’s should be looking good right about now :) imagine when this is $6-7 again
there seemed to be a lot of 2.99s but doubt theylll last long
Wow, I need grab some COEP tomorrow morning before it gets back over 3. Hope I'm not too late for some upper 2s.....
Followers
|
109
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
11906
|
Created
|
03/04/10
|
Type
|
Free
|
Moderators |
"Coeptis Therapeutics is a biopharmaceutical
company developing innovative cell therapy
platforms for patients with cancer."
OUR MISSION:
"TO IMPROVE OUTCOMES FOR PATIENTS WITH CANCER"
Various immunotherapies for CD38+ tumors are designed to find and kill cells that express the CD38 antigen;
therefore, CD38+ NK cells are likely to become collateral damage and with their eradication, the overall anti-tumor response is suboptimal.
To protect CD38+ Natural Killer (NK) cells so that functional disease-targeting NK cells will not be eradicated, enabling their co-existence with
CD38 targeting therapies, and thus allowing tumor killing and immune surveillance.
Modified NK cells that are co-administered with select monoclonal antibodies and/or other CD38 targeting immunotherapies are in pre-clinical development to enhance and
maximize tumor kill via combinatorial approaches otherwise not possible.
Coeptis Therapeutics Holdings, Inc. conducts its commercial operations primarily through its wholly-owned subsidiary Coeptis Pharmaceuticals, Inc.
Coeptis Therapeutics Holdings, Inc.
Corporate Headquarters
105 Bradford Road, Suite 420
Wexford, PA 15090
+1 (724) 934-6467
As of March 30, 2023 • 12:02 PM ET
As of March 30, 2023 • 12:02 PM ET
DATE/TIME | SOURCE | NEWS RELEASE |
---|---|---|
03/27/2023 10:47 AM EDT | SeekingAlpha | NBRV, JNCE and ALIM among healthcare movers |
03/27/2023 08:52 AM EDT | SeekingAlpha | IOVA, MQ and ONCS are among pre market gainers |
03/22/2023 08:30 AM EDT | InvestorBrandNetwork | InvestorNewsBreaks - Coeptis Therapeutics Holdings Inc. (NASDAQ: COEP) Tech Spotlighted in Article in Peer-Reviewed Translational Medicine Journal |
06/23/2022 05:27 PM EDT | SeekingAlpha | I-Mab Valuation Offers A Biotech Investment Opportunity |
04/22/2022 03:00 PM EDT | SeekingAlpha | Catalyst watch: Apple earnings, Twitter drama and media eyes on NAB Show |
04/19/2022 01:50 PM EDT | SeekingAlpha | Coeptis Therapeutics to merge with SPAC Bull Horn, uplist to Nasdaq |
04/13/2022 07:48 AM EDT | SeekingAlpha | Statera Biopharma stock soars 31% on potential drug platform acquisition by Coeptis Therapeutics |
05/18/2021 08:53 AM EDT | SeekingAlpha | Coeptis inks exclusive option agreements with VyGen-Bio |
DISCLAIMER:
Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions.
There is no express or implied solicitation to buy or sell securities.
The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned.
Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for
information purposes only.
No stock exchange has approved or disapproved of the information here.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |